[Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer]

Zentralbl Chir. 2014 Feb;139(1):32-6. doi: 10.1055/s-0033-1360295. Epub 2014 Feb 28.
[Article in German]

Abstract

Background: Therapy for oesophageal carcinoma is a subject of controversial debate. The aim of this study is to answer the question how the therapeutic decision in patients with operable, non-metastatic oesophageal cancer should be made.

Materials and methods: A systematic literature research regarding different therapeutic strategies in patients with oesophageal cancer was undertaken.

Results: Multiple criteria influence the therapy for oesophageal carcinoma. Radical oesophagectomy in a multimodal setting is the therapy of choice. Definitive chemoradiation is a conservative option for high risk patients.

Conclusion: Therapeutic decisions in patients with oesophageal cancer should only be made after standardised staging and accurate risk analysis.

Publication types

  • Comparative Study
  • English Abstract
  • Review

MeSH terms

  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy*
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy*
  • Chemoradiotherapy*
  • Combined Modality Therapy
  • Esophageal Neoplasms / mortality
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / therapy*
  • Esophagectomy*
  • Humans
  • Neoadjuvant Therapy*
  • Neoplasm Staging
  • Randomized Controlled Trials as Topic
  • Survival Rate

Supplementary concepts

  • Adenocarcinoma Of Esophagus